Inventor
WANG XIAOJING
US55 patents
⚠️ This page may combine multiple inventors who share the name “WANG XIAOJING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
15 patentsUS9980947B2May 29, 2018
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
GENENTECH INC17 citations93
US10966963B2Apr 6, 2021
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
GENENTECH INC10 citations84
US9845291B2Dec 19, 2017
Estrogen receptor modulators and uses thereof
GENENTECH INC15 citations84
US10053451B2Aug 21, 2018
Heterocyclic estrogen receptor modulators and uses thereof
GENENTECH INC2 citations73
US9434725B2Sep 6, 2016
5-azaindazole compounds and methods of use
GENENTECH INC4 citations72
US8669361B2Mar 11, 2014
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
GENENTECH INC2 citations63
US12233052B2Feb 25, 2025
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
GENENTECH INC0 citations62
US10399939B2Sep 3, 2019
Tetrahydronaphthalene estrogen receptor modulators and uses thereof
GENENTECH INC1 citations62
US10654867B2May 19, 2020
Heteroaryl estrogen receptor modulators and uses thereof
GENENTECH INC1 citations61
US9573943B2Feb 21, 2017
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
GENENTECH INC1 citations52
US9931323B2Apr 3, 2018
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
GENENTECH INC0 citations51
US9850239B2Dec 26, 2017
Pyrazolo[3,4-c]pyridine compounds and methods of use
GENENTECH INC1 citations51
US9328106B2May 3, 2016
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
GENENTECH INC1 citations51
US9505746B2Nov 29, 2016
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
GENENTECH INC0 citations50
US8614206B2Dec 24, 2013
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
GENENTECH INC0 citations50
ADP LLC
6 patentsUSD794667SAug 15, 2017
Display screen or portion thereof with graphical user interface
ADP LLC61 citations96
USD794666SAug 15, 2017
Display screen or portion thereof with graphical user interface
ADP LLC73 citations96
USD798892SOct 3, 2017
Display screen or portion thereof with animated graphical user interface
ADP LLC20 citations91
US11164135B2Nov 2, 2021
Systems and methods for commute analysis and modeling
ADP LLC0 citations58
US10474978B2Nov 12, 2019
Systems and methods for commute analysis and modeling
ADP LLC1 citations58
US11120385B2Sep 14, 2021
Job level prediction
ADP LLC0 citations47
ISIS PHARMACEUTICALS INC
3 patentsUS7893039B2Feb 22, 2011
Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
ISIS PHARMACEUTICALS INC42 citations95
US8377896B2Feb 19, 2013
Antibacterial 4,6-substituted 6′, 6″ and 1 modified aminoglycoside analogs
ISIS PHARMACEUTICALS INC5 citations73
US8742078B2Jun 3, 2014
Antibacterial 4,6-substituted 6′, 6″ and 1 modified aminoglycoside analogs
ISIS PHARMACEUTICALS INC2 citations63
WANG XIAOJING
3 patentsGILEAD CONNECTICUT INC
3 patentsUS9505785B2Nov 29, 2016
Pyridone and aza-pyridone compounds and methods of use
GILEAD CONNECTICUT INC3 citations71
US10344040B2Jul 9, 2019
Pyridone and aza-pyridone compounds and methods of use
GILEAD CONNECTICUT INC0 citations51
US10053469B2Aug 21, 2018
Pyridone and aza-pyridone compounds and methods of use
GILEAD CONNECTICUT INC0 citations51
BEIJING BOE OPTOELECTRONICS TECH CO LTD
3 patentsUS11495163B2Nov 8, 2022
Grayscale compensation method, grayscale compensation assembly, and liquid crystal display device
BEIJING BOE OPTOELECTRONICS TECH CO LTD1 citations59
US11170724B2Nov 9, 2021
Method for driving a display panel, driving device for driving a display panel and display device
BEIJING BOE OPTOELECTRONICS TECH CO LTD1 citations59
US11276363B2Mar 15, 2022
Display driving control circuit, display panel and driving control method
BEIJING BOE OPTOELECTRONICS TECH CO LTD0 citations49
CELL PATHWAYS INC
2 patentsUS6180629B1Jan 30, 2001
[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
CELL PATHWAYS INC28 citations92
US6486158B1Nov 26, 2002
[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
CELL PATHWAYS INC17 citations84
SWAYZE ERIC E
2 patentsTOSHIBA MEDICAL SYS CORP
2 patentsCURRIE KEVIN S
2 patentsDO STEVEN
1 patentBARBOSA ANTONIO J M
1 patentSAILUN GROUP CO LTD
1 patentJAGTAP PRAKASH
1 patentBLOMGREN PETER A
1 patentGOOGLE LLC
1 patentQUELLMALZ ARNE
1 patentADP INC
1 patentMAXIM NATURE GREEN ENERGY SOLUTIONS LTD
1 patentShowing the top 50 of 55 patents by PatentIndex Score.